These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30306378)

  • 1. mTOR and ERK regulate VKORC1 expression in both hepatoma cells and hepatocytes which influence blood coagulation.
    Liu Y; Li H; Dong J; Ma L; Liao A; Rong Z; Zhou Z; Cao L; Wang F; Wang J; Wang A
    Clin Exp Med; 2019 Feb; 19(1):121-132. PubMed ID: 30306378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Des-gamma-carboxy prothrombin antagonizes the effects of Sorafenib on human hepatocellular carcinoma through activation of the Raf/MEK/ERK and PI3K/Akt/mTOR signaling pathways.
    Cui SX; Shi WN; Song ZY; Wang SQ; Yu XF; Gao ZH; Qu XJ
    Oncotarget; 2016 Jun; 7(24):36767-36782. PubMed ID: 27167344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium dehydroacetate-induced disorder of coagulation function in broiler chickens and the protective effect afforded by vitamin K.
    Xu J; Hao F; Wang C; Zhao Z; Zhang M; Chen X; Zhang Y
    Poult Sci; 2023 Mar; 102(3):102482. PubMed ID: 36706663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VKORC1L1, An Enzyme Mediating the Effect of Vitamin K in Liver and Extrahepatic Tissues.
    Lacombe J; Ferron M
    Nutrients; 2018 Jul; 10(8):. PubMed ID: 30050002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6-stimulated progranulin expression contributes to the malignancy of hepatocellular carcinoma cells by activating mTOR signaling.
    Liu F; Zhang W; Yang F; Feng T; Zhou M; Yu Y; Yu X; Zhao W; Yi F; Tang W; Lu Y
    Sci Rep; 2016 Feb; 6():21260. PubMed ID: 26879559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VKOR paralog VKORC1L1 supports vitamin K-dependent protein carboxylation in vivo.
    Lacombe J; Rishavy MA; Berkner KL; Ferron M
    JCI Insight; 2018 Jan; 3(1):. PubMed ID: 29321368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of VKORC1 and VKORC1L1 signaling in the effects of sodium dehydroacetate on coagulation factors in rat hepatocytes.
    Zhou Z; Chen B; Zhang M; Chen X; Zhang Y
    Toxicol In Vitro; 2023 Mar; 87():105518. PubMed ID: 36403723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two enzymes catalyze vitamin K 2,3-epoxide reductase activity in mouse: VKORC1 is highly expressed in exocrine tissues while VKORC1L1 is highly expressed in brain.
    Caspers M; Czogalla KJ; Liphardt K; Müller J; Westhofen P; Watzka M; Oldenburg J
    Thromb Res; 2015 May; 135(5):977-83. PubMed ID: 25747820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapamycin regulates the proliferation of Huh7, a hepatocellular carcinoma cell line, by up-regulating p53 expression.
    Kwon S; Jeon JS; Ahn C; Sung JS; Choi I
    Biochem Biophys Res Commun; 2016 Oct; 479(1):74-9. PubMed ID: 27616194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual inhibition of the PI3K/AKT/mTOR pathway suppresses the growth of leiomyosarcomas but leads to ERK activation through mTORC2: biological and clinical implications.
    Fourneaux B; Chaire V; Lucchesi C; Karanian M; Pineau R; Laroche-Clary A; Italiano A
    Oncotarget; 2017 Jan; 8(5):7878-7890. PubMed ID: 28002802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
    Ushio K; Hashimoto T; Kitamura N; Tanaka T
    Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum components and activated Ha-ras antagonize expression of perivenous marker genes stimulated by beta-catenin signaling in mouse hepatocytes.
    Braeuning A; Menzel M; Kleinschnitz EM; Harada N; Tamai Y; Köhle C; Buchmann A; Schwarz M
    FEBS J; 2007 Sep; 274(18):4766-77. PubMed ID: 17697114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VKCFD2 - from clinical phenotype to molecular mechanism.
    Czogalla KJ; Watzka M; Oldenburg J
    Hamostaseologie; 2016 Nov; 36(Suppl. 2):S13-S20. PubMed ID: 27824210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth inhibitory actions of prothrombin on normal hepatocytes: influence of matrix.
    Carr BI; Kar S; Wang M; Wang Z
    Cell Biol Int; 2007 Sep; 31(9):929-38. PubMed ID: 17490900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ERK-dependent mTOR pathway is involved in berberine-induced autophagy in hepatic steatosis.
    He Q; Mei D; Sha S; Fan S; Wang L; Dong M
    J Mol Endocrinol; 2016 Nov; 57(4):251-260. PubMed ID: 27658958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Insights into Phylloquinone (Vitamin K1), Menaquinone (MK4, MK7), and Menadione (Vitamin K3) Binding to VKORC1.
    Chatron N; Hammed A; Benoît E; Lattard V
    Nutrients; 2019 Jan; 11(1):. PubMed ID: 30609653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of combined inhibition of mTOR and ERK/MAPK pathways in treating a tuberous sclerosis complex cell model.
    Mi R; Ma J; Zhang D; Li L; Zhang H
    J Genet Genomics; 2009 Jun; 36(6):355-61. PubMed ID: 19539245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-induced serine phosphorylation of IRS-2 via ERK1/2 and mTOR: studies on the function of Ser675 and Ser907.
    Fritsche L; Neukamm SS; Lehmann R; Kremmer E; Hennige AM; Hunder-Gugel A; Schenk M; Häring HU; Schleicher ED; Weigert C
    Am J Physiol Endocrinol Metab; 2011 May; 300(5):E824-36. PubMed ID: 21098738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E2 upregulates EGF-stimulated signaling in mitogenic pathways involving Akt and ERK in hepatocytes.
    Dajani OF; Meisdalen K; Guren TK; Aasrum M; Tveteraas IH; Lilleby P; Thoresen GH; Sandnes D; Christoffersen T
    J Cell Physiol; 2008 Feb; 214(2):371-80. PubMed ID: 17654493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tanshinone IIA induces autophagic cell death via activation of AMPK and ERK and inhibition of mTOR and p70 S6K in KBM-5 leukemia cells.
    Yun SM; Jung JH; Jeong SJ; Sohn EJ; Kim B; Kim SH
    Phytother Res; 2014 Mar; 28(3):458-64. PubMed ID: 23813779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.